NOD-IN-1 is primarily used in research settings to study the NOD-like receptor (NLR) signaling pathway, particularly its role in inflammation and immune responses. It serves as a selective inhibitor of NOD1, a key intracellular pattern recognition receptor involved in detecting bacterial components. By inhibiting NOD1, researchers can investigate its contribution to inflammatory diseases, such as Crohn's disease, arthritis, and other autoimmune conditions. Additionally, NOD-IN-1 helps in understanding the molecular mechanisms of innate immunity and the potential therapeutic targeting of NOD1 in chronic inflammatory disorders. Its application extends to drug development, where it aids in identifying new anti-inflammatory agents.